Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

XenoPort, Inc.

Home Clinical Trial Sponsors and OrganizationsXenoPort, Inc.

XenoPort, Inc.

ACTIVE

6 Concourse Pkwy Ste 1800, 加利福尼亚州圣克拉拉县, California, United Statesxenoport.comSubsidiary251–500 employeesEstablished: 1999-01-01

Part of Arbor Pharmaceuticals LLC

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

26

0 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

1999

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 2

11

42.3%

Phase 1

6

23.1%

Phase 3

6

23.1%

Phase 4

3

11.5%

Trial Status Distribution

Completed

23

88.5%

Unknown

2

7.7%

Withdrawn

1

3.9%

Clinical Trials

Trials sponsored by this organization (26)

An Efficacy and Safety Evaluation of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS

Feb 2016132 participants

An Extension Study to Evaluate the Efficacy and Safety of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS

Jan 2016144 participants

A PK and Safety Evaluation of HORIZANT (Gabapentin Enacarbil) in Adolescents With Moderate-to-Severe Primary RLS

Gabapentin Enacarbil (GSK1838262) Adult Restless Leg Syndrome (RLS) Post Marketing Commitment Study

Jun 2012501 participants

A Study to Evaluate the Effect of Gabapentin on Cardiac Repolarization in Healthy Volunteers

Jan 201252 participants

Drug Drug Interaction Study With Gabapentin Enacarbil and Morphine

Aug 201118 participants

Study to Assess the Effect of Gabapentin Enacarbil on Simulated Driving in Healthy Subjects

Jun 201136 participants

Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis

May 2011228 participants

Page 1 of 4

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials26
Approvals
News

Back to Organizations